Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.18 - $0.86 $3,937 - $18,810
-21,873 Reduced 47.21%
24,460 $6,000
Q1 2022

May 16, 2022

SELL
$0.6 - $1.06 $128,410 - $226,858
-214,017 Reduced 82.2%
46,333 $27,000
Q4 2021

Feb 14, 2022

BUY
$0.85 - $1.4 $140,150 - $230,836
164,883 Added 172.71%
260,350 $236,000
Q3 2021

Nov 09, 2021

BUY
$1.33 - $1.77 $32,313 - $43,003
24,296 Added 34.14%
95,467 $128,000
Q2 2021

Aug 13, 2021

SELL
$1.41 - $1.94 $105,679 - $145,403
-74,950 Reduced 51.29%
71,171 $103,000
Q1 2021

May 13, 2021

BUY
$1.61 - $2.77 $93,009 - $160,022
57,770 Added 65.39%
146,121 $263,000
Q4 2020

Feb 11, 2021

SELL
$1.55 - $2.24 $1,173 - $1,695
-757 Reduced 0.85%
88,351 $154,000
Q3 2020

Nov 12, 2020

SELL
$1.91 - $3.08 $41,926 - $67,609
-21,951 Reduced 19.77%
89,108 $173,000
Q2 2020

Aug 12, 2020

BUY
$1.97 - $3.98 $131,834 - $266,345
66,921 Added 151.62%
111,059 $307,000
Q1 2020

May 13, 2020

SELL
$1.17 - $3.0 $105,007 - $269,250
-89,750 Reduced 67.03%
44,138 $132,000
Q4 2019

Feb 10, 2020

BUY
$1.16 - $1.42 $80,679 - $98,762
69,551 Added 108.1%
133,888 $165,000
Q3 2019

Nov 14, 2019

SELL
$1.21 - $1.65 $22,031 - $30,043
-18,208 Reduced 22.06%
64,337 $86,000
Q2 2019

Aug 14, 2019

BUY
$1.39 - $2.03 $67,515 - $98,601
48,572 Added 142.97%
82,545 $139,000
Q1 2019

May 15, 2019

BUY
$1.39 - $1.71 $43,302 - $53,271
31,153 Added 1104.72%
33,973 $51,000
Q4 2018

Feb 14, 2019

SELL
$1.41 - $2.16 $58,805 - $90,084
-41,706 Reduced 93.67%
2,820 $4,000
Q3 2018

Nov 14, 2018

BUY
$1.86 - $2.18 $67,371 - $78,961
36,221 Added 436.13%
44,526 $93,000
Q2 2018

Aug 14, 2018

SELL
$1.76 - $2.79 $23,930 - $37,935
-13,597 Reduced 62.08%
8,305 $16,000
Q1 2018

May 15, 2018

BUY
$1.34 - $2.03 $7,643 - $11,579
5,704 Added 35.21%
21,902 $40,000
Q4 2017

Feb 14, 2018

BUY
$1.65 - $2.45 $22,821 - $33,885
13,831 Added 584.33%
16,198 $29,000
Q3 2017

Nov 14, 2017

BUY
$1.5 - $2.55 $3,550 - $6,035
2,367
2,367 $5,000

About ATHERSYS, INC


  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.